RNA-programmed genome editing in human cells
Martin Jínek, Alexandra East, Aaron T. Cheng et al. · eLife · 2013
Type II CRISPR immune systems in bacteria use a dual RNA-guided DNA endonuclease, Cas9, to cleave foreign DNA at specific sites. We show here that Cas9 assembles with hybrid guide RNAs in human cells and can induce the formation of double-strand DNA breaks (DSBs) at a site complementary to the guide RNA sequence in genomic DNA. This cleavage activity requires both Cas9 and the complementary binding of the guide RNA. Experiments using extracts from transfected cells show that RNA expression and/or assembly into Cas9 is the limiting factor for Cas9-mediated DNA cleavage. In addition, we find that extension of the RNA sequence at the 3' end enhances DNA targeting activity in vivo. These results show that RNA-programmed genome editing is a facile strategy for introducing site-specific genetic changes in human cells.DOI:http://dx.doi.org/10.7554/eLife.00471.001.
Cited by 2,092 works. doi:10.7554/elife.00471 Open-access PDF
Authors
References
- A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
- CRISPR RNA maturation by trans-encoded small RNA and host factor RNase III
- Cas9–crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria
- RNA-guided genetic silencing systems in bacteria and archaea
- Genome editing with engineered zinc finger nucleases
- An improved zinc-finger nuclease architecture for highly specific genome editing
- The Streptococcus thermophilus CRISPR/Cas system provides immunity in Escherichia coli
- CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation
- CRISPR-based adaptive immune systems
- TAL Effectors: Customizable Proteins for DNA Targeting